drugset / Trial / NCT05234840

"Platelet-Rich Plasma" Epidural Injection an Emerging Strategy in Lumbar Disc Herniation

NCT05234840 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

To evaluate the efficacy of platelet-rich plasma (PRP; double-spin) in treatment of single-level lumbar herniated nucleus pulposus (HNP) in comparison to triamcinolone. RCT was conducted with 30 patients included.

Timeline

Start
2019-04-01
Primary completion
2021-05-01
Completion
2021-06-30

Outcome

Met primary endpoint

paper Patients treated by PRP injections showed statistically and clinically significant reduction in LegVAS at 6, 12, and 24 weeks PMID 37118707 ↗

paper Noncommercial epidural double-spin PRP yielded superior results to triamcinolone. PMID 37118707 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 4 ml Other
Comparator Triamcinolone Other / unclassified 40 mg Other
Comparator Lidocaine Other / unclassified 1 % —

Indications

No indication recorded.